CareDx to Participate in Jefferies Healthcare Conference
CareDx, a precision medicine company focused on healthcare solutions for transplant patients, announced its participation in the Jefferies Virtual Healthcare Conference.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
CareDx, a precision medicine company focused on healthcare solutions for transplant patients, announced its participation in the Jefferies Virtual Healthcare Conference. The event will take place on June 1, 2021, at 10:00 a.m. PT / 1:00 p.m. ET. Investors can access the live webcast through the investor relations section of CareDx's website. CareDx specializes in testing services and digital solutions along the transplant patient journey, making it a leading provider of genomics-based information for transplant care.
Details
News Market Reaction – CDNA
The recorded move for CDNA in the trading session of this news was -1.37%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SOUTH SAN FRANCISCO, Calif., May 27, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced today the Company plans to participate in the Jefferies Virtual Healthcare Conference.
CareDx’s management will be participating in the Jefferies Virtual Healthcare Conference on Tuesday, June 1, 2021 at 10:00 a.m Pacific time / 1:00 p.m. Eastern time. To listen to a live webcast, please visit the investor relations section of CareDx’s website at: investors.caredxinc.com.
About CareDx
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.
CONTACTS:
CareDx, Inc.
Sasha King
Chief Marketing Officer
415-287-2393
sking@caredx.com
Investor Relations
Greg Chodaczek
347-610-7010
investor@caredx.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.